Literature DB >> 27163190

Disruption of Akt signaling decreases dopamine sensitivity in modulation of inhibitory synaptic transmission in rat prefrontal cortex.

Yan-Chun Li1, Sha-Sha Yang1, Wen-Jun Gao2.   

Abstract

Akt is a serine/threonine kinase, which is dramatically reduced in the prefrontal cortex (PFC) of patients with schizophrenia, and a deficiency in Akt1 results in PFC function abnormalities. Although the importance of Akt in dopamine (DA) transmission is well established, how impaired Akt signaling affects the DA modulation of synaptic transmission in the PFC has not been characterized. Here we show that Akt inhibitors significantly decreased receptor sensitivity to DA by shifting DA modulation of GABAA receptor-mediated inhibitory postsynaptic currents (IPSCs) in prefrontal cortical neurons. Akt inhibition caused a significant decrease in synaptic dopamine D2 receptor (D2R) levels with high-dose DA exposure. In addition, Akt inhibition failed to affect DA modulation of IPSCs after blockade of β-arrestin 2. β-arrestin 2-mediated interaction of clathrin with D2R was enhanced by co-application of a Akt inhibitor and DA. Taken together, the reduced response in DA modulation of inhibitory transmission mainly involved β-arrestin 2-dependent D2R desensitization.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; Dopamine; Dopamine receptors; Inhibitory synaptic transmission; Prefrontal cortex; Schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27163190      PMCID: PMC5505175          DOI: 10.1016/j.neuropharm.2016.05.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  66 in total

Review 1.  Neuroimaging of cognitive disability in schizophrenia: search for a pathophysiological mechanism.

Authors:  J D Ragland; J Yoon; M J Minzenberg; C S Carter
Journal:  Int Rev Psychiatry       Date:  2007-08

2.  Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory.

Authors:  Susheel Vijayraghavan; Min Wang; Shari G Birnbaum; Graham V Williams; Amy F T Arnsten
Journal:  Nat Neurosci       Date:  2007-02-04       Impact factor: 24.884

Review 3.  The Akt-GSK-3 signaling cascade in the actions of dopamine.

Authors:  Jean-Martin Beaulieu; Raul R Gainetdinov; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2007-03-08       Impact factor: 14.819

4.  Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.

Authors:  H Hall; G Sedvall; O Magnusson; J Kopp; C Halldin; L Farde
Journal:  Neuropsychopharmacology       Date:  1994-12       Impact factor: 7.853

5.  Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.

Authors:  Kuntebommanahalli N Thimmaiah; John B Easton; Glen S Germain; Christopher L Morton; Shantaram Kamath; John K Buolamwini; Peter J Houghton
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

Review 6.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

7.  Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

Authors:  Y Okubo; T Suhara; K Suzuki; K Kobayashi; O Inoue; O Terasaki; Y Someya; T Sassa; Y Sudo; E Matsushima; M Iyo; Y Tateno; M Toru
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

8.  Altered dopamine modulation of inhibition in the prefrontal cortex of cocaine-sensitized rats.

Authors:  Sven Kroener; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2010-07-21       Impact factor: 7.853

9.  Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.

Authors:  Sepideh N Bajestan; Amir H Sabouri; Masayuki Nakamura; Hiroshi Takashima; Mohammad R Keikhaee; Fatemeh Behdani; Mohammad R Fayyazi; Mohammad R Sargolzaee; Mahboobeh N Bajestan; Zahra Sabouri; Esmaeil Khayami; Sima Haghighi; Susan B Hashemi; Nobutaka Eiraku; Hamid Tufani; Hossein Najmabadi; Kimiyoshi Arimura; Akira Sano; Mitsuhiro Osame
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

10.  AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.

Authors:  Dawn L Thiselton; Vladimir I Vladimirov; Po-Hsiu Kuo; Joseph McClay; Brandon Wormley; Ayman Fanous; Francis A O'Neill; Dermot Walsh; Edwin J C G Van den Oord; Kenneth S Kendler; Brien P Riley
Journal:  Biol Psychiatry       Date:  2007-09-06       Impact factor: 13.382

View more
  4 in total

1.  New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.

Authors:  Elena Shumay; Corinde E Wiers; Ehsan Shokri-Kojori; Sung Won Kim; Colin A Hodgkinson; Hui Sun; Dardo Tomasi; Christopher T Wong; Daniel R Weinberger; Gene-Jack Wang; Joanna S Fowler; Nora D Volkow
Journal:  J Neurosci       Date:  2017-04-17       Impact factor: 6.167

2.  The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory.

Authors:  Yu-Xiang Zhang; Rita C Akumuo; Rodrigo A España; Chun-Xia Yan; Wen-Jun Gao; Yan-Chun Li
Journal:  Neuropharmacology       Date:  2018-08-27       Impact factor: 5.250

3.  Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders.

Authors:  William R Reay; Dylan J Kiltschewskij; Michael P Geaghan; Joshua R Atkins; Vaughan J Carr; Melissa J Green; Murray J Cairns
Journal:  Sci Adv       Date:  2022-04-06       Impact factor: 14.136

4.  Prefrontal inhibition of neuronal Kv 7 channels enhances prepulse inhibition of acoustic startle reflex and resistance to hypofrontality.

Authors:  Jing Wang; Wenwen Yu; Qin Gao; Chuanxia Ju; KeWei Wang
Journal:  Br J Pharmacol       Date:  2020-09-17       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.